nach oben

Endocrine

Erschienen in:

17.04.2020 | Meta-Analysis

Rs9939609 polymorphism of the fat mass and obesity-associated (FTO) gene and metabolic syndrome susceptibility in the Chinese population: a meta-analysis

Erschienen in: Endocrine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The relationship between the rs9939609 allele of fat mass and obesity-associated (FTO) gene and metabolic syndrome (MS) susceptibility has been evaluated by many studies, however, the results still remained controversial in the Chinese population. In order to provide more accurate results, we performed this meta-analysis.

Methods

We searched PubMed, and Wanfang Med Online in both English and Chinese, and eight eligible studies comprising of 5345 cases and 9523 controls were eventually selected into our meta-analysis. The meta-analysis was performed using the STATA 12.0 software.

Results

In pooled analysis, the FTO gene rs9939609 polymorphism significantly increased MS susceptibility under per-allele comparisons (A vs. T) (OR 1.21, 95% CI 1.10–1.35, P < 0.001) and in dominant model (OR 1.35, 95% CI 1.13–1.62, P < 0.001). Subgroup analyses under per-allele comparisons (A vs. T) indicated that the elevated risk was observed in adults (OR 1.26, 95% CI 1.08–1.47, P = 0.003) but not in children and adolescents (OR 1.14, 95% CI 0.95–1.36, P = 0.17), and that the risk for increasing MS was only identified in IDF groups (OR 1.22, 95% CI 1.03–1.43, P = 0.018) but not in NCEP ATP III groups (OR 1.14, 95% CI 0.95–1.36, P = 0.17); in both population-based (PB) and hospital-based (HB) groups, A alleles of rs9939609 appeared to be linked to increased MS susceptibilities (HB group: OR 1.51, 95% CI 1.10–2.08, P = 0.01; PB group: OR 1.19, 95% CI 1.09–1.30, P < 0.001). No significant association was established in dominant model subgroup analyses except PB group (OR 1.29, 95% CI 1.05–1.53, P < 0.001).

Conclusion

Our results suggested that the FTO gene rs9939609 polymorphism significantly increased MS susceptibility in Chinese. Our results should be verified by well-designed studies with larger sample size.

K.G. Alberti, P. Zimmet, J. Shaw; Group, I.D.F.E.T.F.C., The metabolic syndrome—a new worldwide definition. Lancet 366(9491), 1059–1062 (2005). https://doi.org/10.1016/S0140-6736(05)67402-8 CrossRefPubMed

U. Ekelund, S. Anderssen, L.B. Andersen, C.J. Riddoch, L.B. Sardinha, J. Luan, K. Froberg, S. Brage, Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. Am. J. Clin. Nutr. 89(1), 90–96 (2009). https://doi.org/10.3945/ajcn.2008.26649 CrossRefPubMed

J. Steinberger, S.R. Daniels, R.H. Eckel, L. Hayman, R.H. Lustig, B. McCrindle, M.L. Mietus-Snyder, American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism., Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119(4), 628–647 (2009). https://doi.org/10.1161/CIRCULATIONAHA.108.191394 CrossRefPubMed

C.P. Cannon, Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am. J. Cardiol. 102(12A), 5L–9L (2008). https://doi.org/10.1016/j.amjcard.2008.09.067 CrossRefPubMed

H. Belfki, S. Ben Ali, H. Aounallah-Skhiri, P. Traissac, S. Bougatef, B. Maire, F. Delpeuch, N. Achour, H. Ben Romdhane, Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project. Public Health Nutr. 16(4), 582–590 (2013). https://doi.org/10.1017/S1368980012003291 CrossRefPubMed

Y. Wu, Y. Yu, T. Zhao, S. Wang, Y. Fu, Y. Qi, G. Yang, W. Yao, Y. Su, Y. Ma, J. Shi, J. Jiang, C. Kou, Interactions of environmental factors and APOA1-APOC3-APOA4-APOA5 gene cluster gene polymorphisms with metabolic syndrome. PloS One 11(1), e0147946 (2016). https://doi.org/10.1371/journal.pone.0147946 CrossRefPubMedPubMedCentral

J.H. Yin, Z.Y. Song, P.F. Shan, J. Xu, Z.M. Ye, X.H. Xu, S.Z. Zhang, Q. Liang, Y. Zhao, Z. Ren, Y.P. Yu, Age- and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China. Clin. Endocrinol. 76(6), 802–809 (2012). https://doi.org/10.1111/j.1365-2265.2011.04198.x CrossRef

B. Chen, D. Yang, Y. Chen, W. Xu, B. Ye, Z. Ni, The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin. Chim. Acta 411(9-10), 705–709 (2010). https://doi.org/10.1016/j.cca.2010.01.038 CrossRefPubMed

H. Zuo, Z. Shi, X. Hu, M. Wu, Z. Guo, A. Hussain, Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism 58(8), 1102–1108 (2009). https://doi.org/10.1016/j.metabol.2009.04.008 CrossRefPubMed

10.

T.O. Cheng, Prevalence of metabolic syndrome is still underestimated in the Chinese population. Int. J. Cardiol. 116(2), 257–258 (2007). https://doi.org/10.1016/j.ijcard.2006.04.050 CrossRefPubMed

11.

B. Fathi Dizaji, The investigations of genetic determinants of the metabolic syndrome. Diabetes Metab. Syndr. 12(5), 783–789 (2018). https://doi.org/10.1016/j.dsx.2018.04.009 CrossRefPubMed

12.

E. Fanning, D. O’Shea, Genetics and the metabolic syndrome. Clin. Dermatol. 36(1), 9–13 (2018). https://doi.org/10.1016/j.clindermatol.2017.09.003 CrossRefPubMed

13.

E. Zeggini, M.N. Weedon, C.M. Lindgren, T.M. Frayling, K.S. Elliott, H. Lango, N.J. Timpson, J.R. Perry, N.W. Rayner, R.M. Freathy, J.C. Barrett, B. Shields, A.P. Morris, S. Ellard, C.J. Groves, L.W. Harries, J.L. Marchini, K.R. Owen, B. Knight, L.R. Cardon, M. Walker, G.A. Hitman, A.D. Morris, A.S. Doney, M.I. McCarthy, A.T. Hattersley, Wellcome Trust Case Control Consortium, Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316(5829), 1336–1341 (2007). https://doi.org/10.1126/science.1142364 CrossRefPubMedPubMedCentral

14.

C. Dina, D. Meyre, S. Gallina, E. Durand, A. Korner, P. Jacobson, L.M. Carlsson, W. Kiess, V. Vatin, C. Lecoeur, J. Delplanque, E. Vaillant, F. Pattou, J. Ruiz, J. Weill, C. Levy-Marchal, F. Horber, N. Potoczna, S. Hercberg, C. Le Stunff, P. Bougneres, P. Kovacs, M. Marre, B. Balkau, S. Cauchi, J.C. Chevre, P. Froguel, Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39(6), 724–726 (2007). https://doi.org/10.1038/ng2048 CrossRefPubMed

15.

A. Hinney, T.T. Nguyen, A. Scherag, S. Friedel, G. Bronner, T.D. Muller, H. Grallert, T. Illig, H.E. Wichmann, W. Rief, H. Schafer, J. Hebebrand, Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PloS One 2(12), e1361 (2007). https://doi.org/10.1371/journal.pone.0001361 CrossRefPubMedPubMedCentral

16.

T.M. Frayling, N.J. Timpson, M.N. Weedon, E. Zeggini, R.M. Freathy, C.M. Lindgren, J.R. Perry, K.S. Elliott, H. Lango, N.W. Rayner, B. Shields, L.W. Harries, J.C. Barrett, S. Ellard, C.J. Groves, B. Knight, A.M. Patch, A.R. Ness, S. Ebrahim, D.A. Lawlor, S.M. Ring, Y. Ben-Shlomo, M.R. Jarvelin, U. Sovio, A.J. Bennett, D. Melzer, L. Ferrucci, R.J. Loos, I. Barroso, N.J. Wareham, F. Karpe, K.R. Owen, L.R. Cardon, M. Walker, G.A. Hitman, C.N. Palmer, A.S. Doney, A.D. Morris, G.D. Smith, A.T. Hattersley, M.I. McCarthy, A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889–894 (2007). https://doi.org/10.1126/science.1141634 CrossRefPubMedPubMedCentral

17.

D. Zhou, H. Liu, M. Zhou, S. Wang, J. Zhang, L. Liao, F. He, Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome. Mol. Biol. Rep. 39(6), 6555–6561 (2012). https://doi.org/10.1007/s11033-012-1484-4 CrossRefPubMed

18.

C.M. Povel, J.M. Boer, E. Reiling, E.J. Feskens, Genetic variants and the metabolic syndrome: a systematic review. Obes. Rev. 12(11), 952–967 (2011). https://doi.org/10.1111/j.1467-789X.2011.00907.x CrossRefPubMed

19.

H. Wang, S. Dong, H. Xu, J. Qian, J. Yang, Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol. Biol. Rep. 39(5), 5691–5698 (2012). https://doi.org/10.1007/s11033-011-1377-y CrossRefPubMed

20.

Y.H. Hu, J.M. Liu, M. Zhang, R.L. Ma, H. Guo, K. Wang, J. He, Y.Z. Yan, D.S. Rui, F. Sun, L.T. Mu, Q. Niu, Y.S. Ding, J.Y. Zhang, S.G. Li, S.X. Guo, Association between polymorphisms of fat mass and obesity-associated gene and metabolic syndrome in Kazakh adults of Xinjiang, China. Genet. Mol. Res. 14(4), 14597–14606 (2015). https://doi.org/10.4238/2015.November.18.23 CrossRefPubMed

21.

X. Kong, X. Zhang, X. Xing, B. Zhang, J. Hong, W. Yang, The association of type 2 diabetes loci identified in genome-wide association studies with metabolic syndrome and its components in a Chinese population with type 2 diabetes. PloS One 10(11), e0143607 (2015). https://doi.org/10.1371/journal.pone.0143607 CrossRefPubMedPubMedCentral

22.

X. Zhao, B. Xi, Y. Shen, L. Wu, D. Hou, H. Cheng, J. Mi, An obesity genetic risk score is associated with metabolic syndrome in Chinese children. Gene 535(2), 299–302 (2014). https://doi.org/10.1016/j.gene.2013.11.006 CrossRefPubMed

23.

W. Wu, Study on the Hui and Han children and adolescent with metabolic syndrome and MS with the gene FTO rs9939609 polymorphism. Master’s Thesis of Ningxia Medical University. Yinchuan, China (2016) (Publication in Chinese)

24.

A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603–605 (2010). https://doi.org/10.1007/s10654-010-9491-z CrossRefPubMed

25.

S.A. Al-Attar, R.L. Pollex, M.R. Ban, T.K. Young, P. Bjerregaard, S.S. Anand, S. Yusuf, B. Zinman, S.B. Harris, A.J. Hanley, P.W. Connelly, M.W. Huff, R.A. Hegele, Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc. Diabetol. 7, 5 (2008). https://doi.org/10.1186/1475-2840-7-5 CrossRefPubMedPubMedCentral

26.

T. Wang, Y. Huang, X.H. Xiao, D.M. Wang, C.M. Diao, F. Zhang, L.L. Xu, Y.B. Zhang, W.H. Li, L.L. Zhang, Y. Zhang, X.F. Sun, Q. Zhang, The association between common genetic variation in the FTO gene and metabolic syndrome in Han Chinese. Chin. Med. J. 123(14), 1852–1858 (2010)PubMed

27.

Q. Wan, B. Zhou, J. Fan, Q. Li, H. Wang, Effect of interactions between FTO gene variation and lifestyle on metabolic syndrome. Med. J. Chin. People’s Liberation Army 35(5), 513–516 (2010) (Publication in Chinese)

28.

Z. Xu, J. Song, H. Wang, G. Li, Study on the relationship between MC4R, FTO gene polymorphisms and metabolic syndrome-related phenotypes. Mod. Prev. Med. 39(8), 1866–1870 (2012) (Publication in Chinese)

29.

T. Gerken, C.A. Girard, Y.C. Tung, C.J. Webby, V. Saudek, K.S. Hewitson, G.S. Yeo, M.A. McDonough, S. Cunliffe, L.A. McNeill, J. Galvanovskis, P. Rorsman, P. Robins, X. Prieur, A.P. Coll, M. Ma, Z. Jovanovic, I.S. Farooqi, B. Sedgwick, I. Barroso, T. Lindahl, C.P. Ponting, F.M. Ashcroft, S. O’Rahilly, C.J. Schofield, The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318(5855), 1469–1472 (2007). https://doi.org/10.1126/science.1151710 CrossRefPubMedPubMedCentral

30.

Z. Han, T. Niu, J. Chang, X. Lei, M. Zhao, Q. Wang, W. Cheng, J. Wang, Y. Feng, J. Chai, Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 464(7292), 1205–1209 (2010). https://doi.org/10.1038/nature08921 CrossRefPubMed

31.

M. Rask-Andersen, M.S. Almen, H.R. Olausen, P.K. Olszewski, J. Eriksson, R.A. Chavan, A.S. Levine, R. Fredriksson, H.B. Schioth, Functional coupling analysis suggests link between the obesity gene FTO and the BDNF-NTRK2 signaling pathway. BMC Neurosci. 12, 117 (2011). https://doi.org/10.1186/1471-2202-12-117 CrossRefPubMedPubMedCentral

32.

P.K. Olszewski, R. Fredriksson, J.D. Eriksson, A. Mitra, K.J. Radomska, B.A. Gosnell, M.N. Solvang, A.S. Levine, H.B. Schioth, Fto colocalizes with a satiety mediator oxytocin in the brain and upregulates oxytocin gene expression. Biochem. Biophys. Res. Commun. 408(3), 422–426 (2011). https://doi.org/10.1016/j.bbrc.2011.04.037 CrossRefPubMed

33.

P.K. Olszewski, R. Fredriksson, A.M. Olszewska, O. Stephansson, J. Alsio, K.J. Radomska, A.S. Levine, H.B. Schioth, Hypothalamic FTO is associated with the regulation of energy intake not feeding reward. BMC Neurosci. 10, 129 (2009). https://doi.org/10.1186/1471-2202-10-129 CrossRefPubMedPubMedCentral

34.

A. Auton, L.D. Brooks, R.M. Durbin, E.P. Garrison, H.M. Kang, J.O. Korbel, J.L. Marchini, S. McCarthy, G.A. McVean, G.R:. Abecasis,1000 Genomes Project Consortium, A global reference for human genetic variation. Nature 526(7571), 68–74 (2015). https://doi.org/10.1038/nature15393 CrossRefPubMed

35.

L. Brunkwall, U. Ericson, S. Hellstrand, B. Gullberg, M. Orho-Melander, E. Sonestedt, Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults. Food Nutr. Res. 57 (2013). https://doi.org/10.3402/fnr.v57i0.20028

36.

J.E. Cecil, R. Tavendale, P. Watt, M.M. Hetherington, C.N. Palmer, An obesity-associated FTO gene variant and increased energy intake in children. N. Engl. J. Med. 359(24), 2558–2566 (2008). https://doi.org/10.1056/NEJMoa0803839 CrossRefPubMed

37.

M. Tanofsky-Kraff, J.C. Han, K. Anandalingam, L.B. Shomaker, K.M. Columbo, L.E. Wolkoff, M. Kozlosky, C. Elliott, L.M. Ranzenhofer, C.A. Roza, S.Z. Yanovski, J.A. Yanovski, The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am. J. Clin. Nutr. 90(6), 1483–1488 (2009). https://doi.org/10.3945/ajcn.2009.28439 CrossRefPubMedPubMedCentral

Titel: Rs9939609 polymorphism of the fat mass and obesity-associated (FTO) gene and metabolic syndrome susceptibility in the Chinese population: a meta-analysis
Publikationsdatum: 17.04.2020
Erschienen in: Endocrine / Ausgabe 2/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02280-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Rs9939609 polymorphism of the fat mass and obesity-associated (FTO) gene and metabolic syndrome susceptibility in the Chinese population: a meta-analysis

Abstract

Purpose

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Periprostatic paraganglioma causing occult Cushing’s syndrome

The efficacy of vitamin D combined with clomiphene citrate in ovulation induction in overweight women with polycystic ovary syndrome: a double blind, randomized clinical trial

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome

The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond

Post-transplant diabetes mellitus: incidence, predicting factors and outcomes

A bridge too far? Attempting to bridge the treatment gap in osteoporosis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin